# RAPAMUNE
> **NDA021110** · New Drug Application · Sponsor: PF PRISM CV · Approved 2000-08-25
## Drug
- **FDA Application Number:** NDA021110
- **Application type:** New Drug Application
- **Brand name:** RAPAMUNE
- **Generic name:** SIROLIMUS
- **Active ingredients:** SIROLIMUS
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** PF PRISM CV
- **Manufacturer:** Mylan Pharmaceuticals Inc.
- **First approval:** 2000-08-25
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021110)
---
*AI Analytics · CC0 1.0*